A detailed history of Univest Financial Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Univest Financial Corp holds 38,486 shares of BMY stock, worth $2.21 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
38,486
Holding current value
$2.21 Million
% of portfolio
0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $1.53 Million - $1.99 Million
38,486 New
38,486 $1.99 Million
Q4 2021

Feb 08, 2022

SELL
$53.63 - $62.52 $200,790 - $234,074
-3,744 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $2,070 - $2,425
35 Added 0.94%
3,744 $222,000
Q2 2021

Jul 20, 2021

BUY
$61.91 - $67.42 $229,624 - $250,060
3,709 New
3,709 $247,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Univest Financial Corp Portfolio

Follow Univest Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Univest Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Univest Financial Corp with notifications on news.